Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of Periapical Inflammation Following Nano-Calcium Hydroxide and Nano-Chitosan Intracanal Medications
NCT07571837Recruiting
- Sponsor
- Al-Azhar University
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, triple-blind trial in Apical periodontitis (AP) (3 arms), sponsored by Al-Azhar University. Primary endpoint: Interleukin-10 and Tumor Necrosis Factor-alpha levels at 1 week. Started Oct 2026; status: recruiting.
02
Conditions
Apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07571837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07571837.